|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.28/-0.03
|
Enterprise Value
69.39M
|
Balance Sheet |
Book Value Per Share
0.18
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
3.23M
|
Operating Revenue Per Share
0.06
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/01/21 05:25 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications. |